Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer
Ricardo Hitt, Ricard Mesı́a, Alicia Lozano, Lara Iglesias Docampo, Juan J. Grau, Miren Taberna, Jordi Rubió‐Casadevall, Javier Martínez‐Trufero, E. del Barco, Carlos García Girón, Sergio Vázquez Estévez, Beatriz Cirauqui, Juan Jesús Cruz
Topics & Concepts
MedicineCetuximabDocetaxelFluorouracilRadiation therapyOncologyHazard ratioInternal medicineChemoradiotherapyHead and neck cancerClinical endpointCisplatinInduction chemotherapyChemotherapyAdverse effectRandomized controlled trialCancerConfidence intervalColorectal cancerHead and Neck Cancer StudiesEsophageal Cancer Research and TreatmentHead and Neck Surgical Oncology